IBKR Launches Shenzhen-Hong Kong Connect Program, Expanding Access to China’s Emerging Industries
Interactive Brokers Group, Inc. (NASDAQ:IBKR) has released its year-end IB Communiqué informing clients worldwide about its new Shenzhen-Hong Kong Stock Connect program. The company also rolled out enhancements to its IBot trading technology and IB Trader Workstation℠ platform (TWS) and launched new CME Globex products.
Shenzhen-Hong Kong Connect Program Launched
Interactive Brokers established a new Shenzhen-Hong Kong Stock Connect Program in November. This follows the 2014 creation of the Shanghai-Hong Kong Stock Connect program, which opened the Shanghai Stock Exchange to IB’s Hong Kong and international clients. With the new Shenzhen program, China continues to expand the stocks that are available to trade.
“As an exchange participant in this program, IB’s Hong Kong and international clients can now trade designated Chinese securities on the Shenzhen Stock Exchange, giving them expanded access to China’s emerging industries,” said Steven Sanders, Executive Vice President of Marketing and Product Development at Interactive Brokers.
Get details on the Shenzhen Stock Exchange here .
IB Trader Workstation Now Offers Multilingual Voice Feedback
Clients can now customize IB’s desktop TWS platform to provide audio feedback for all key actions in their native language.
IBot Now Available on Mobile Devices
IBot, a language interface to trading, is now available on iOS as well as on the IB Trader Workstation. The voice recognition for mobile devices has been customized to comprehend financial terms. IBot understands commands relating to quotes, charts, orders, trades, market scanners, Level II data and account information. IBot users can now trade on the go, in addition to accessing quotes and charts.
This year, IB made many improvements to its mobile trading platform – IB TWS for Mobile. These include enhancements to Order Entry, Option Chains and charts. IB’s mobile software lets clients trade from their IB account on almost any mobile device.
Facilitating trading further, Chinese clients can now get Traders Workstation for their Android devices from their local stores such as Baidu and Qihoo360.
New Financial Products Launched
Interactive Brokers expanded its product offerings this quarter to include CME Globex Natural Gas options.
For more new developments, read the entire year-end IB Communiqué here .
About Interactive Brokers Group, Inc.:
Interactive Brokers Group, Inc., together with its subsidiaries, is an automated global electronic broker that specializes in catering to financial professionals by offering state-of-the-art trading technology, superior execution capabilities, worldwide electronic access, and sophisticated risk management tools at exceptionally low costs.
The brokerage trading platform utilizes the same innovative technology as the Company’s market making business, which specializes in routing orders and executing and processing trades in securities, futures, foreign exchange instruments, bonds and funds on more than 100 electronic exchanges and trading venues around the world. As a market maker, we provide liquidity at these marketplaces and, as a broker, we provide professional traders and investors with electronic access to stocks, options, futures, forex, bonds and mutual funds from a single IB Universal Account℠ .
Employing proprietary software on a global communications network, Interactive Brokers is continuously integrating its software with a growing number of exchanges and trading venues into one automatically functioning, computerized platform that requires minimal human intervention.
Interactive Brokers Group, Inc.
Nancy Stuebe, 203-618-4070
Kalen Holliday, 203-913-1369
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
DE-INCYTE21.10.2018 12:47 | pressemeddelelse
Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma
SERVIER21.10.2018 11:12 | pressemeddelelse
Servier and Taiho Oncology Announce Phase III LONSURF® Study Has Met Primary and Secondary Endpoints Demonstrating Prolonged Overall Survival and Progression-Free Survival in Patients with Refractory Metastatic Gastric Cancer
IL-GILEAD-SCIENCES21.10.2018 00:32 | pressemeddelelse
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum